Heritage Wealth Advisors Compass Pathways PLC Transaction History

Heritage Wealth Advisors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 12, 2024	BUY	$7.79 - $10.69 $194 - $267	25 New	25 $0
Q2 2023 Aug 09, 2023	SELL	$7.79 - $10.69 $7,790 - $10,690	-1,000 Reduced 97.56%	25 $0
Q3 2022 Dec 12, 2024	BUY	$10.73 - $20.07 $10,998 - $20,571	1,025 New	1,025 $10,000
Q3 2022 Nov 10, 2022	SELL	$10.73 - $20.07 $11,212 - $20,973	-1,045 Reduced 50.48%	1,025 $11,000
Q1 2022 May 11, 2022	SELL	$11.13 - $23.04 $11,686 - $24,192	-1,050 Reduced 33.65%	2,070 $27,000
Q2 2021 Aug 09, 2021	BUY	$32.29 - $39.68 $20,988 - $25,792	650 Added 26.32%	3,120 $119,000
Q2 2021 Jul 27, 2021	SELL	$32.29 - $39.68 $20,988 - $25,792	-650 Reduced 20.83%	2,470 $118,000
Q1 2021 Apr 27, 2021	BUY	$34.75 - $57.5 $22,587 - $37,375	650 Added 26.32%	3,120 $114,000
Q4 2020 Feb 01, 2021	BUY	$32.0 - $59.2 $79,040 - $146,224	2,470 New	2,470 $118,000

151

33.6M

536K

582K

Ticker CMPS
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 42,522,400
Market Cap $363M
Description
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...

Get notified when there are updates to the investment portfolio of Heritage Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Heritage Wealth Advisors with notifications on news.